News out on Steller Biotechnologies as it announces an Exclusive Agreement
Stellar Biotechnologies Acquires Exclusive, Worldwide License to Clostridium Difficile Immunotherapy Technology PORT HUENEME, CA– Stellar Biotechnologies, Inc. (“Stellar” or ̶…
